Nearly five million asthmatics worldwide could benefit from antifungal therapy
Wednesday, May 8, 2013 - 11:00
in Health & Medicine
An estimated 4,837,000 asthmatics with allergic bronchopulmonary aspergillosis (ABPA) could benefit substantially from antifungal treatment, say researchers.